Eligibility for outpatient treatment with low-molecular-weight heparin in venous thromboembolism.
Tanvetyanon
T
T
Cohn
J B
JB
D000553:Ambulatory Care / Q000592:standards*; D000925:Anticoagulants / Q000627:therapeutic use*; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use*; D006801:Humans; D008499:Medical Records; D018579:Patient Selection; D015143:Philadelphia; D012189:Retrospective Studies; D013923:Thromboembolism / Q000188:drug therapy*; D014481:United States
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight